US Stock MarketDetailed Quotes

CNTB Connect Biopharma

Watchlist
  • 1.0600
  • +0.0300+2.91%
Close Nov 29 13:00 ET
58.41MMarket Cap-2717P/E (TTM)

Connect Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
52.79%-47.93M
-20.39%-101.52M
-229.57%-84.32M
-98.35%-25.59M
-12.9M
Net income from continuing operations
49.59%-59.38M
41.69%-117.79M
-69.36%-202M
-394.89%-119.27M
---24.1M
Operating gains losses
81.76%-272K
-406.16%-1.49M
-47.84%487K
401.60%933.68K
---309.57K
Depreciation and amortization
-4.17%988K
62.62%1.03M
187.05%634K
95.62%220.87K
--112.91K
Other non cash items
-50.79%-2.01M
-19,114.29%-1.33M
-98.42%7K
5,745.74%442.81K
--7.57K
Change In working capital
46.85%9.49M
80.47%6.46M
921.02%3.58M
-118.58%-435.92K
--2.35M
-Change in receivables
-74.22%1.04M
275.63%4.05M
-61.13%-2.31M
-230.91%-1.43M
---432.48K
-Change in payables and accrued expense
-1,544.29%-4.75M
-103.99%-289K
354.66%7.24M
-47.05%1.59M
--3.01M
-Change in other current assets
-95.55%120K
298.67%2.7M
-127.14%-1.36M
-160.95%-597.86K
---229.1K
-Change in other working capital
--13.07M
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
52.79%-47.93M
-20.39%-101.52M
-229.57%-84.32M
-98.35%-25.59M
---12.9M
Investing cash flow
Cash flow from continuing investing activities
187.14%75.16M
-1,556.29%-86.24M
-1,260.26%-5.21M
193.98%448.78K
-477.5K
Net PPE purchase and sale
160.14%2.65M
39.46%-4.41M
-217.86%-7.28M
-1,394.03%-2.29M
---153.21K
Net intangibles purchase and sale
--0
--0
10.14%-48K
---53.42K
--0
Net investment purchase and sale
188.70%72.59M
-3,965.75%-81.84M
-24.16%2.12M
960.72%2.79M
---324.29K
Net other investing changes
---84K
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
187.14%75.16M
-1,556.29%-86.24M
-1,260.26%-5.21M
193.98%448.78K
---477.5K
Financing cash flow
Cash flow from continuing financing activities
-189.41%-246K
-100.04%-85K
43.80%202.22M
248,570.15%140.63M
-56.6K
Net issuance payments of debt
-30.63%-290K
-76.19%-222K
-53.01%-126K
-29.48%-82.35K
---63.6K
Net common stock issuance
144.44%44K
-99.99%18K
--219.42M
--0
--0
Proceeds from stock option exercised by employees
--0
250.00%119K
--34K
--0
--7K
Net other financing activities
----
----
-112.16%-17.11M
--140.71M
----
Cash from discontinued financing activities
Financing cash flow
-189.41%-246K
-100.04%-85K
43.80%202.22M
248,570.15%140.63M
---56.6K
Net cash flow
Beginning cash position
-70.49%79.01M
72.94%267.72M
227.34%154.8M
-17.61%47.29M
--57.4M
Current changes in cash
114.36%26.98M
-266.70%-187.85M
-2.43%112.69M
959.70%115.49M
---13.43M
Effect of exchange rate changes
102.10%18K
-483.04%-858K
102.74%224K
-4,282.63%-8.18M
--195.52K
End cash Position
34.17%106.01M
-70.49%79.01M
73.16%267.72M
250.11%154.6M
--44.16M
Free cash flow
54.47%-48.22M
-15.58%-105.93M
-228.15%-91.65M
-113.96%-27.93M
---13.05M
Currency Unit
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 52.79%-47.93M-20.39%-101.52M-229.57%-84.32M-98.35%-25.59M-12.9M
Net income from continuing operations 49.59%-59.38M41.69%-117.79M-69.36%-202M-394.89%-119.27M---24.1M
Operating gains losses 81.76%-272K-406.16%-1.49M-47.84%487K401.60%933.68K---309.57K
Depreciation and amortization -4.17%988K62.62%1.03M187.05%634K95.62%220.87K--112.91K
Other non cash items -50.79%-2.01M-19,114.29%-1.33M-98.42%7K5,745.74%442.81K--7.57K
Change In working capital 46.85%9.49M80.47%6.46M921.02%3.58M-118.58%-435.92K--2.35M
-Change in receivables -74.22%1.04M275.63%4.05M-61.13%-2.31M-230.91%-1.43M---432.48K
-Change in payables and accrued expense -1,544.29%-4.75M-103.99%-289K354.66%7.24M-47.05%1.59M--3.01M
-Change in other current assets -95.55%120K298.67%2.7M-127.14%-1.36M-160.95%-597.86K---229.1K
-Change in other working capital --13.07M----------------
Cash from discontinued investing activities
Operating cash flow 52.79%-47.93M-20.39%-101.52M-229.57%-84.32M-98.35%-25.59M---12.9M
Investing cash flow
Cash flow from continuing investing activities 187.14%75.16M-1,556.29%-86.24M-1,260.26%-5.21M193.98%448.78K-477.5K
Net PPE purchase and sale 160.14%2.65M39.46%-4.41M-217.86%-7.28M-1,394.03%-2.29M---153.21K
Net intangibles purchase and sale --0--010.14%-48K---53.42K--0
Net investment purchase and sale 188.70%72.59M-3,965.75%-81.84M-24.16%2.12M960.72%2.79M---324.29K
Net other investing changes ---84K----------------
Cash from discontinued investing activities
Investing cash flow 187.14%75.16M-1,556.29%-86.24M-1,260.26%-5.21M193.98%448.78K---477.5K
Financing cash flow
Cash flow from continuing financing activities -189.41%-246K-100.04%-85K43.80%202.22M248,570.15%140.63M-56.6K
Net issuance payments of debt -30.63%-290K-76.19%-222K-53.01%-126K-29.48%-82.35K---63.6K
Net common stock issuance 144.44%44K-99.99%18K--219.42M--0--0
Proceeds from stock option exercised by employees --0250.00%119K--34K--0--7K
Net other financing activities ---------112.16%-17.11M--140.71M----
Cash from discontinued financing activities
Financing cash flow -189.41%-246K-100.04%-85K43.80%202.22M248,570.15%140.63M---56.6K
Net cash flow
Beginning cash position -70.49%79.01M72.94%267.72M227.34%154.8M-17.61%47.29M--57.4M
Current changes in cash 114.36%26.98M-266.70%-187.85M-2.43%112.69M959.70%115.49M---13.43M
Effect of exchange rate changes 102.10%18K-483.04%-858K102.74%224K-4,282.63%-8.18M--195.52K
End cash Position 34.17%106.01M-70.49%79.01M73.16%267.72M250.11%154.6M--44.16M
Free cash flow 54.47%-48.22M-15.58%-105.93M-228.15%-91.65M-113.96%-27.93M---13.05M
Currency Unit USDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data